Stuart Poulton joined Karyopharm in February 2022 as Senior Vice President, Strategy and Portfolio Management and was promoted to Chief Development Officer in July 2022. Mr. Poulton is responsible for leading Karyopharm’s Product Strategy and Portfolio Management Team, Clinical Operations, Data Management, Medical Writing, and Quality.
Mr. Poulton has more than 25 years of experience in the global biotech and pharmaceutical space. He joined Karyopharm from AbbVie, where he served as the Vice President of Clinical Development Operations and previously as the Vice President for Portfolio Program Management. Mr. Poulton also spent more than a decade at Amgen, where he held leadership roles of increasing responsibility in global program and portfolio management. He started his career in clinical operations at Eli Lilly.
Mr. Poulton holds a Bachelor of Science in Pharmacology and Chemistry from the University of Sydney and a Master of Commerce in Marketing from the University of New South Wales.